Role of Triple Therapy in Asthma
Asthma is a chronic inflammatory airway disease characterised by variable airflow obstruction and recurrent symptoms such as wheeze, breathlessness, and cough. While many patients achieve control with standard inhaled therapies, a significant proportion remain symptomatic despite appropriate treatment, requiring escalation of care. Triple therapy—combining inhaled corticosteroids (ICS), long-acting beta-agonists (LABA), and long-acting muscarinic antagonists (LAMA)—has emerged as an important step-up treatment for patients with uncontrolled asthma. It targets multiple pathophysiological pathways, offering broader bronchodilation and anti-inflammatory effects.

Learning Outcomes
What you'll learn
- Understand the components and mechanism of triple therapy in asthma.
- Identify patients who may benefit from triple therapy.
- Apply evidence-based guidance for step-up asthma management.
- Implement triple therapy safely and effectively in clinical practice.
- Monitor treatment response and adjust therapy accordingly.
- Educate patients to improve adherence and outcomes.
Stay updated with our


Learning Outcomes
What you'll learn
- Understand the components and mechanism of triple therapy in asthma.
- Identify patients who may benefit from triple therapy.
- Apply evidence-based guidance for step-up asthma management.
- Implement triple therapy safely and effectively in clinical practice.
- Monitor treatment response and adjust therapy accordingly.
- Educate patients to improve adherence and outcomes.
Stay updated with our


Training Overview
- Understanding Triple Therapy in Asthma
- Indications for Triple Therapy
- Clinical Evidence and Benefits
- Practical Implementation in Clinical Practice
- Monitoring and Safety Considerations
- Patient Education and Long-Term Management
- Summary
.jpg)

.jpg)

.jpg)

.jpg)
Top reviews
No reviews yet.
You May Also Like
Are you a qualified
Trainer or Instructor?
Join Care Learning as a trainer and deliver high-quality courses to learners across healthcare and workplace training.
Refer a Friend &
Earn Rewards.
Invite healthcare professionals to join Care Learning and get rewarded when your referral successfully joins.
Frequently asked questions
A combination of ICS, LABA, and LAMA used for patients with uncontrolled asthma.
When asthma remains uncontrolled despite ICS/LABA therapy.
Additional bronchodilation and improved symptom control.
Yes, it improves FEV1 and reduces exacerbations.
No, it is used as a step-up therapy.
It improves adherence and treatment outcomes.
.jpg)
.jpg)
.jpg)



